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Abstract 
Purpose 
Radiation therapy (RT) is often recommended in the treatment of pelvic cancers. Following RT, a 
high prevalence of pelvic floor dysfunctions (urinary incontinence, dyspareunia, and fecal 
incontinence) is reported. However, changes in pelvic floor muscles (PFMs) after RT remain 
unclear. The purpose of this review was to systematically document the effects of RT on the 
PFM structure and function in patients with cancer in the pelvic area. 
Methods 
An electronic literature search using Pubmed Central, CINAHL, Embase, and SCOPUS was 
performed from date of inception up to June 2014. The following keywords were used: 
radiotherapy, muscle tissue, and pelvic floor. Two reviewers selected the studies in accordance 
with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA). 
Out of the 369 articles screened, 13 met all eligibility criteria. The methodological quality was 
assessed using the QualSyst scoring system, and standardized mean differences were calculated. 
Results 
Thirteen studies fulfilled all inclusion criteria, from which four were of good methodological 
quality. One presented strong evidence that RT affects PFM structure in men treated for 
prostate cancer. Four presented high-level evidence that RT affects PFM function in patients 
treated for rectal cancer. Meta-analysis was not possible due to heterogeneity and lack of 
descriptive statistics. 
Conclusion 
There is some evidence that RT has detrimental impacts on both PFMs’ structure and function. 
Implications for cancer survivors 
A better understanding of muscle damage and dysfunction following RT treatment will improve 
pelvic floor rehabilitation and, potentially, prevention of its detrimental impacts. 
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Introduction 
Pelvic cancers, such as urogynecological and colorectal cancers, are common afflictions. 
Colorectal cancers account for 13 % of all new cancer diagnoses in Canada. For men, prostate 
cancers account for 25 % of all new cases, while in women, gynecological cancers account for 13 
% [1]. Radiation therapy is often recommended in the treatment of such cancers. It can be used 
pre-operatively and/or post-operatively in order not only to treat the malignancy itself, but also 
to decrease the risk of recurrence. Adjuvant radiation can be administered externally (external 
beam radiation therapy) or intra-cavitary by probe or radioactive implants (brachytherapy) [2]. 
There are direct and indirect effects of radiation to the pelvic organs and musculature. Lesions 
such as stenosis, agglutination, or shortening of the vagina have been detailed for women after 
gynecological cancers [3]. Furthermore, a high prevalence of pelvic floor dysfunctions following 
radiotherapy for pelvic neoplasms has also been reported: urinary incontinence and urgency [4, 
5], sexual dysfunction and dyspareunia [6–8], and fecal urgency and incontinence [9, 10]. Such 
dysfunctions have been demonstrated not only to cause distress to cancer survivors [11], but 
also to diminish their participation in activities of daily living and social activities, leading to an 
overall decreased quality of life [12]. 
The pelvic floor consists of a network of muscles and fascia, which are attached to the bony 
pelvis. The superficial muscles play an important role in sexual function (bulbospongiosus, 
ischiocavernosus muscles), somewhat not important role in supportive function (transverse 
perineal muscles, perineum body) and in fecal continence (external anal sphincter muscle). The 
intermediate layer is mostly important in maintaining urinary continence (compressor urethra 
muscle, external urinary sphincter, etc.). Lastly, the deep layer includes the levator ani muscles 
(pubococcygeus, ileococcygeus, ischiococcygeus, and puborectalis muscles) which are known to 
play an important role in supporting pelvic organ and maintain continence under increasing 
abdominal pressure [13]. Moreover, the urethra and the anus also have an internal sphincter, 
which are intrinsic muscle layers that also contribute to continence. Together, the pelvic floor 
muscles are highly regulated by complex autonomic and somatic mechanisms to fine-tune their 
contraction and relaxation sequence in order to maintain continence [14]. This is why, for 
people without a history of cancer, pelvic floor muscle rehabilitation is highly recommended to 
treat pelvic floor dysfunctions like urinary incontinence or urgency [15]. Recently, trials have 
been initiated to identify better treatment options for pelvic floor dysfunctions in women after 
gynecological cancer treatment. These studies reported, after intensive pelvic floor muscle 
rehabilitation, decreased urinary incontinence, decreased sexual dysfunctions, and improved 
quality of life, without adverse effects [16, 17]. From instructing how to correctly contract the 
pelvic floor muscles and do the home exercises, to one-on-one biofeedback training sessions, 
pelvic floor physiotherapists played a crucial role in the rehabilitation process in these studies. 
However, little is known regarding objectivable muscle changes following radiation therapy. Ooi 
et al. [18] overviewed common complications after adjuvant therapies in the treatment of rectal 
cancers, and the authors did identify the need for further understanding of the pelvic floor and 
sphincter function. In order to improve the treatment approaches for these dysfunctions, it is 
imperative to have a better understanding of muscle tissue changes induced by radiation. Such 
changes can be described, using the International Classification of Functioning, Disability and 
Health (ICF model), as any impairments to the anatomical structure of the muscle tissues or to 
the physiological functions of the muscles relative to their power, tone, endurance, or other 
specified muscle functions [19]. For brevity, the short terms “structure” and “function” are used 
henceforth to refer to muscle changes. This article systematically reviews the documented 
effects of radiation therapy on the pelvic floor muscle (PFM) structure [19] and function in 
patients with cancer in the pelvic area (including gynecological, prostatic, or colorectal cancers) . 
Method 
Literature search 
This review was conducted according to the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses Statement (PRISMA) [20]. A systematic search of the electronic databases 
Pubmed Central, CINAHL, Embase, and SCOPUS was conducted from date of inception up to 
June 2014. The word concepts used for the search were as follows: radiotherapy as the medical 
intervention and pelvic floor as the targeted muscles. Muscle tissue, as the targeted body tissue, 
was added to the search since there was a need for increased precision of the results. All the 
synonyms and associated subterms were combined using the operator “OR” and, afterward, 
were combined altogether with the other concepts by the operator “AND.” Two reviewers (SB 
and MPO) independently screened the titles and the abstracts for each reference, according to 
the established inclusion and exclusion criteria. Consensus was obtained through discussion 
when there was disagreement. The articles retained for full-text review were screened again by 
the two reviewers to reassess further meeting of all eligibility criteria. Lastly, the reference lists 
of the eligible articles were screened to verify if additional suitable studies, not previously 
identified with the databases systematic search, would be found. Once included after full-text 
review, data and results were extracted with a standardized form including the following: study 
design, participants’ characteristics (such as age, sex, type of cancer), radiation intervention, 
outcome measures, follow-up period, and main results of interest. The first reader extracted the 
data (SB), and the second reader (MPO) corroborated or completed it if data were missing. 
 
 
Eligibility criteria 
The articles met the inclusion criteria if they had (1) at least one group of adults or elderly 
patients with a diagnosis of cancer in the pelvic area treated by/with radiotherapy and (2) an 
outcome measure for the PFM structure or function. The articles were excluded if they did not 
present original results or if they involved resection of the PFMs. No limits were applied for 
language, and no case of inaccessible translation occurred. No limits were applied regarding 
length of follow-up since short-term and long-term effects of radiotherapy have been outlined 
before [21]. No limits were applied to the type of pelvic cancer, since the maximal dose 
tolerance from these organs overlaps (ranging between 50 and 100 Gy, with 60–70 Gy for most 
pelvic organs) and because vicinity to the PFMs is similar [22–24]. 
Assessment of methodological quality and meta-analysis 
Since the eligible articles were mostly non-experimental studies (prospective, retrospective, 
cross-sectional studies, etc.), the quality assessment for evaluating primary research studies 
(QualSyst) was used to evaluate the methodological quality and the risk of bias of the included 
studies [25]. An overview of the checklist used for scoring can be found in Table 2. This 
assessment tool has been shown to be moderately reliable [25]. For this review, the first four 
authors met after independent assessment of two papers in order to ensure proper score 
allocation. Afterward, every included paper was subjected to the QualSyst criteria checklist by 
two independent raters. They met to compare scores and resolve differences. Since summary 
scores are not yet associated to different qualitative categories, we used the following index to 
categorize the results to the following: “excellent quality” for scores higher than 80.0 %, of 
“good quality” for scores between 65.0 and 80.0 %, of “moderate quality” for scores between 
50.0 and 64.9 %, and of “low quality” for scores below 50.0 %. For the synthesis of results, meta-
analytic tools such as effect sizes were used when possible, using means and standard 
deviations of irradiated subjects and their control values. When these statistics were not 
published, contact was attempted with the authors in order to obtain the necessary statistics. 
Afterward, standardized mean differences (SMD) were used as summary measure of the results 
of several independent studies to appreciate the magnitude of the impact of radiation therapy 
(RT) on specific variables characterizing PFM structure and function [26]. The interpretation of 
the calculated effect sizes (d) followed the guidelines proposed by Cohen [27]. 
Results 
Characteristics of selected studies 
Figure 1 summarizes the results of the literature search. Searches yielded 369 results, from 
which 243 records remained after duplicates were removed. Following screening of the 
abstracts and full-text review, 13 studies fulfilled all inclusion criteria. Only one randomized 
controlled trial could be included in the review since pre-radiation baseline measures were 
available for comparison to the post-radiation measures. The other articles were mostly cohort 
(6), cross-sectional (3), quasi-experimental (1), case series (1), and case-control (1) studies. Five 
of the selected articles included participants (men or women) with colorectal cancer and anal 
cancer, five included men with prostate cancer, one included men with both prostate and rectal 
cancer, and lastly, two included women with cervical cancer. From retrievable data, age for all 
participants ranged from 34 to 81 years old with a mean of 61.4 years old. There were 160 
women compared to 532 men, for an approximate total of 692 participants (some data are 
missing from control groups to allow an exact sum). The mean time between radiation and 
assessment was 78 weeks. A brief description of study populations and RT protocols is provided 
in Table 1. 
 
 
Fig. 1 
PRISMA flowchart of the article selection process 
 
Table 1 
Demographic data and RT protocols for studies included in the review 
  Men 
(n) 
Women 
(n) 
Age 
(years) 
BMI 
(kg/m2) 
RT 
assessment 
interval 
(weeks) 
Type of 
cancer 
Type of RT 
[28] 61 34 63.3 26.3 6 Colorectal Post-operative, 
total dose 
50.4 ± 2 Gy 
(1.8 Gy five 
times/week), 
type of 
radiation 
unspecified 
[29] – – 63a – 113 Anal Percutaneous 
radiation 
therapy was a 
mean of 
56.1 Gy 
(for n = 21), 
and additional 
BT for a mean 
of 7.2 Gy in 16 
patients 
[30] 0 24 63 24.9 416 Cervix 
(mainly) 
EBRT (either 
abdominal or 
pelvic), total 
dose between 
44 and 64 Gy 
during 30 to 
56 days. 
[31] 2 0 – – 208 Prostate 
and rectal 
72 Gy 
administered 
  Men 
(n) 
Women 
(n) 
Age 
(years) 
BMI 
(kg/m2) 
RT 
assessment 
interval 
(weeks) 
Type of 
cancer 
Type of RT 
in 40 fractions 
[32] 128 0 66.9 – 90 Prostate n = 45 
underwent 
EBRT (median 
dose, 
86.4 Gy),n = 29 
underwent BT 
(median dose, 
144 Gy), 
and n = 34 
patients 
underwent a 
combination of 
BT (median 
dose for 
iodine-125, 
110 Gy, for 
palladium-103, 
100 Gy, and for 
iridium-192, 
21 Gy) and 
EBRT (median 
dose, 50.4 Gy) 
[33] 35 0 68 26 5 Prostate EBRT: 
between 55 
and 64 Gy, 
administered 
during 4 to 
6.5 weeks 
  Men 
(n) 
Women 
(n) 
Age 
(years) 
BMI 
(kg/m2) 
RT 
assessment 
interval 
(weeks) 
Type of 
cancer 
Type of RT 
[34] 34 0 68 26 72.8 Prostate EBRT: 
between 55 
and 64 Gy, 
administered 
during 4 to 
6.5 weeks 
[35] 35 0 59 – 52 Prostate BT by seeds 
(125 seeds 
forn = 24 and 
103 seeds 
for n = 11) 
For n = 7, there 
was additional 
EBRT 
[36] 0 60 51.6 26.2 27 Cervix Combination 
of EBRT (dose 
of 45 to 
50.4 Gy) and 
intra-cavitary 
BT, without 
extended-field 
irradiation 
[37] 6 5 56.4 – 7 Rectal 50-Gy 
irradiation in 
25 fractions 
administered 
over a 5-week 
period 
(2 Gy/fraction) 
  Men 
(n) 
Women 
(n) 
Age 
(years) 
BMI 
(kg/m2) 
RT 
assessment 
interval 
(weeks) 
Type of 
cancer 
Type of RT 
[38] 161 0 68.6 27.3 8 Prostate IMRT with a 
dose of 78 Gy 
in 39 fractions 
given in five 
fractions per 
week 
[39] 39 27 63 – 4 Rectal 45 Gy 
administered 
in 25 fractions 
(5 weeks): 
for n = 26, 
there was 
EBRT, and 
forn = 20, 
there was 
irradiation of 
the superior 
pelvis (anal 
canal 
excluded) 
[40] 31a 10a 61b – 5 Rectal 45 Gy in 
fractions at 
1.5 Gy per day 
treated daily, 
5 days a week 
BMI body mass index, RT radiation therapy, BT brachytherapy, EBRT external beam radiation 
therapy, IMRT intensity-modulated radiotherapy, Gy Gray, – unavailable data 
aData from subgroup related to our variables of interest 
bOnly data from irradiated subjects, controls’ characteristics unavailable  
Outcome measures 
The impact of RT on the PFM structure was studied in eight articles (Table 3). Muscle structure 
integrity was assessed using anal manometry (for sphincter length measurements), endoscopic 
ultrasound, MRI, and histology (microscopic) analysis. Ten papers reported results related to 
PFM function (Table 4). The tools and methods used for these measurements were manual 
muscle testing through digital palpation (Oxford Scale), anorectal perfusion manometry, and 
surface EMG (more details below). Five of the studies presented data related to both structure 
and function. 
The effects of RT on PFM structure 
Of the eight articles that studied PFM structure after RT, three compared the irradiated subjects 
to non-cancer, non-irradiated subjects [28–30], another one to a subject with cancer who did 
not receive radiation [31], and three compared to pre-radiation measures for their cohort study 
[32–34], and the last study had no control group [35]. In these studies, the effects of radiation 
were observed through evaluation of the changes in the muscle tissue itself, such as its 
dimension, morphology, or composition (Table 3). These articles were mostly of “good” quality, 
but one obtained 100 % [32] on the quality assessment (Table 2). In the quasi-experimental 
study by Allgayer et al. [28], only the post-radiation measures assessed before an experimental 
exercise program were used, which were anal sphincter length measured by anal perfusion 
manometry, internal anal sphincter diameter, and external anal sphincter diameter measured 
by endoscopic ultrasound. Their results show no or weak effect (effect size 0.17) of radiation on 
sphincter length of men pre- to post-radiotherapy for colorectal cancer (Table 3). As the 
measures from the anal sphincter’s diameters were not presented in the results by the authors, 
this article concludes to a non-significant impact of radiation on the muscle’s structure solely 
from the anal sphincter’s length measures. Similar measures were taken in a study by 
Vordermark et al. [29]. This paper did find a significantly shorter (p = 0.03) sphincter’s length 
with irradiated subjects (no surgery) compared to healthy volunteers. The first study reviewed 
from Yeoh et al. [30] reported measures of maximal thickness for external and internal anal 
sphincters from anal ultrasound in cervical cancer patients. No significant differences were 
found between the subjects and healthy controls for these variables. The effect size for the 
maximal thickness of the external anal sphincter was in accordance with this result (effect size 
0.14), but the effect size for the thickness of the internal anal sphincter suggests a moderate 
detrimental effect of RT (effect size −0.72). Similar conclusions were drawn from a prospective 
cohort study conducted by the same author; no differences were found between pre- and post-
radiation measures of maximal thickness of the external and internal anal sphincters in men 
treated for prostate cancer in acute [33] and chronic [34] conditions; however, no effect size 
could be calculated from available data. Another study by Gervaz et al. [31] presented an 
interesting case study with measures until 4 years post-radiation. On histology analysis, the 
presence of immunoreactivity of tumor growth factor β1 (TGF-β1) and connective tissue growth 
factor (CTGF) was significantly higher in anal sphincter strips from an irradiated subject than 
from a non-irradiated subject, especially in the smooth muscles cells. This translates into 
prolonged radiation-induced fibrosis into muscle tissues, especially in the smooth layer muscle 
cells. These findings support the hypothesis not only that radiation affects the muscle structure 
of the pelvic floor through increase fibrotic tissue, but also that these effects seem to be still 
ongoing 4 years after radiation. Furthermore, Coakley et al. [35] used MRI as a measurement 
tool to observe that 97.1 % of their subjects presented with radiation-induced changes in the 
levator ani muscles, as demonstrated by increased signal intensity in these structures and 80.0 
% in the urogenital diaphragm muscles after brachytherapy by radioactive implants. Along with 
these findings, Marigliano et al. [32] also used MRI to assess the radiation-induced changes in 
periurethral muscles and in periprostatic portion of the levator ani muscles and also measured 
the urethral length. The authors observed not only that there was a significant reduction of the 
urethral length pre- to post-radiation, but also that there was an increased signal intensity in the 
periurethral (in 70 to 86 % of cases) and periprostatic portion of the levator ani (in 90 to 96 % of 
cases) post-RT, suggesting fibrotic changes in these muscle tissues. These data show a moderate 
detrimental effect (effect size −0.65) of radiotherapy on the urethral length for men treated for 
prostate cancer (Table 3). Most of these data show a trend supporting the presence of changes 
in the PFM structure after RT in the treatment of prostate and colorectal cancer, except for anal 
sphincter thickness. Since our requests to obtain further precision on presented data remained 
unanswered by most authors and that two studies presented descriptive data in lieu of analytic 
data, only few effect sizes from SMD could be calculated. It was not possible to perform meta-
analysis secondary to heterogeneity between structures under study and lack of descriptive 
statistics. 
 
 
 
The effects of RT on PFM function 
PFM strength 
Seven articles presented data regarding pelvic floor’s function. Two papers compared the 
irradiated subjects to non-cancer, non-irradiated subjects [28, 29] and two more to subjects 
with cancer but who did not receive radiation [36, 37], and three others compared to pre-
radiation measures [38–40]. Two articles rated “low to moderate quality” [40, 29], two rated 
“good quality” [36, 28], and three of “excellent quality” [38, 39, 37] (Table 2). In a retrospective 
cohort study by Theisen et al. [40], resting and maximal squeeze pressure data measured by 
anal manometry was reported (Table 4). A significant decrease in the post-data compared to the 
pre-data was found for these two variables. Furthermore, the results of a cross-sectional study 
by Vordermark et al. [29] demonstrated a decreased anal resting and maximal squeeze pressure 
through manometry for the RT group compared to healthy normals. Manometry was also used 
in the studies by Yeoh et al. [30, 33, 34], where anal resting and maximal squeeze pressure were 
found decreased in chronic cervical cancer patients [30] 5 to 10 years post-RT compared to 
healthy volunteers. Strong detrimental effect sizes could be calculated from the data of the first 
study (between −0.94 and −1.3), except for resting pressure at anal sleeve where only a weak 
detrimental effect size was calculated (effect size −0.14), The same results were observed in a 
cohort of men treated for prostate cancer [33], between baseline and 4–6 weeks post-RT. 
However, these findings were not maintained after 1 year. In contrast, resting pressure was 
found to be increased with comparison to initial assessment [34], which the authors did not 
offer an explanation for. In their study, Allgayer et al. [28] did not observe significant difference 
between radiated and non-irradiated patients for anal resting and maximal squeeze pressure for 
the same outcome measure. Noronha et al. [36] demonstrated no significant difference 
between the surgical group (RH) and the radiation groups for pelvic floor maximum strength, as 
measured by bidigital palpation. Still, a tendency toward a significant difference was obtained 
when comparing the RH and RT groups (p = 0.06 by omnibus test): we observed that the RT 
group appeared to have a greater proportion of extremely low maximum strength scores (such 
as 0 and 1) on the Oxford scale. Using R 3.0.0 software, we compared RH to RT for the 
proportion of these very low scores (0, 1) vs (2, 3, 4, 5) and a p = 0.03 was obtained, meaning 
that the proportion of very low scores was significantly different between the RH and RT groups. 
This observation could be of clinical importance since incontinence was associated with the 
severity of the weakness of their pelvic floor [41]. Consequently, a trend toward a higher 
proportion of low-strength scores is likely for the subjects who received RT. Dieperink et al. [38], 
in 2013, presented a RCT where pre-RT baseline measures were available. With the 
collaboration of the authors, additional paired t tests (data available in Table 5) were conducted, 
and it was acknowledged that when measured digitally using the Oxford scale, maximal PFM 
contraction, static strength, and dynamic strength were not significantly different pre- to post-
radiation. Lastly, Lim et al. [39] presented short-term effects of preoperative chemoradiation on 
anorectal function using anorectal manometry. Mean maximum resting and maximum squeeze 
pressure were gathered, and maximum squeeze pressure was found to be highly significantly 
decreased (p < 0.0001). 
 
Activity and contractile response of PFMs 
In 2012, Lorenzi et al. [37] measured functional changes to the internal anal sphincter after 
chemoradiation for rectal cancer using drugs and electrical stimulation of sphincter strips in 
organ baths. The results revealed that the strips from irradiated subjects not only expressed less 
spontaneous activity than controls but also decreased contractile response to electrical and 
chemical stimulation. This means that decreased response is not only induced by a 
neuromuscular injury, but also from injury to the muscle fibers themselves. Dieperink et al. [38] 
also presented, in the previously discussed RCT, the PFM average activity measured by EMG 
during a maximal voluntary contraction and found significantly different pre-radiation to post-
radiation EMG activity measures (p < 0.0001), while they did not found significant differences 
when maximum strength was measured digitally. There was also significant difference 
(p = 0.001) between resting EMG activity pre- to post-radiation. However, there was no 
significant difference in EMG activity during maximum voluntary squeeze in women treated by 
RT for cervical cancer in comparison to healthy volunteers in the study by Yeoh et al. [30]. 
Overall, these findings indicate a trend supporting changes in the PFM function after RT in the 
treatment of pelvic cancers such as prostate, colorectal, and gynecological cancers. Effect sizes 
could be calculated from five studies [28, 36, 38, 37, 30] once the necessary data had been 
obtained from the authors. The latter two studies show a strong detrimental effect (effect size 
of −3.8 and −3.9, respectively) of RT on EMG average resting activity, EMG average work activity, 
and spontaneous activity for men treated for prostate and rectal cancer [38, 37]. Although, the 
strong effect sizes obtained from non-significantly different variables reflect possible 
irregularities in their data distribution. The former three studies on the other hand show weak 
to strong detrimental effect (effect sizes between −0.14 and −1.26) of radiation of muscle 
resting pressure and maximum squeeze pressure, i.e., maximal strength for men treated for 
prostate cancer and women treated for cervical cancer [28, 36]. These effect sizes were not 
combined together because of the use of different outcome measures to document muscle 
activity and contractile response of the PFMs. 
Discussion 
The purpose of this study was to systematically review the documented effects of RT on the 
PFM structure and function in pelvic cancer patients. As shown in Tables 3 and 4, there is some 
evidence that RT has a detrimental impact on the PFM structure and function. However, few 
effect sizes were calculable due to missing data. From the available data, it is possible to see 
that the calculated SDM differed substantially between publications, ranging between −0.72 and 
0.17 for effect of radiotherapy on muscle’s structure and between −0.14 to −3.91 for effect on 
muscle’s average function. The evidence was scarce with only 13 included studies for the 
review, and the quality of it was inconsistent (Table 2), as previously reported in the review by 
Ooi et al. [18]. 
 
Effects of RT on the PFM structure 
According to the Oxford Centre for Evidence-Based Medicine [42], there is level 2B evidence 
that RT affects the structure of the PFMs, between 2 and 62 months after radiation, in a 
population of men treated with external beam therapy (EBRT) and/or brachytherapy (BT) for 
prostate cancer. Howbeit, there is also level 2B evidence that these RT-induced changes do not 
include anal sphincter thickness. Out of the eight articles studying these aspects, only two had 
excellent methodological quality [32, 34]. The latter study showed no change of the maximal 
thickness of the external and internal anal sphincters of men irradiated for prostate cancer, 
which is corroborated in two other studies of good methodological quality [30, 33]. The former 
study showed decreased urethral length and increased fibrosis in the levator ani and urogenital 
diaphragm muscles of men irradiated for prostate cancer. This high-quality cohort study strongly 
supports a significant effect of RT on structure. Additionally, their choice of outcome measures 
is fairly robust. Indeed, MRI is a valid measurement tool to assess the structure different muscle 
layers of the pelvic floor in various planes [43–45]. The levator ani muscle’s role is mainly to 
support organs and resist increased abdominal pressure [46]. Fibrotic tissue could affect its 
capacity in fulfilling this role. Additionally, the authors controlled for the type of radiotherapy 
received by the participants and were able to observe that BT was associated with more 
changes in these muscles than EBRT. However, the authors did not propose a hypothesis for this 
phenomenon. It would have been of interest to see if an association existed between the degree 
of radiation-induced changes and the radiation itself. Close enough, Smeenk et al. published in 
2012 a study discussing the relation between the incidence of fecal incontinence to increased 
radiation dosage to specific muscular layers of the pelvic floor [47]. They found that there are 
less incontinence complaints when radiation did not target the PFMs, suggesting that the 
radiation process changed the muscle’s integrity. They suggest that to achieve less anorectal 
complaint after RT, it is necessary to delineate the PFMs anteriorly and plan for ≤30-Gy radiation 
to the internal anal sphincter, ≤10 Gy to the external anal sphincter, and ≤50 Gy to the 
puborectalis muscle in prostate cancer patients. 
For the other reviewed articles [35, 29, 31, 30, 33], an overall trend toward supporting that 
radiation affects the PFM structure is presented with a level 4 evidence. The choice of outcome 
measure was fair: histology was used for one trial, and anal manometry for anal sphincter 
length’s measures in another one. Manometry is shown to be a reliable measure for this 
variable [48]. These studies failed to present stronger level of evidence mainly because of weak 
study design [29, 35] and moderate [31, 29] methodological quality. Only one article did not 
support the impacts of radiotherapy on the PFM structure such as anal sphincter’s length [28]. 
Even though this study has a good quality of methodology, it needs to be mentioned that the 
authors did not reveal the radiation protocol received by the subjects. It is impossible to 
estimate the amount of variability that there could have been in their sample. It is therefore 
difficult to conclude on the additional influence of radiotherapy to surgery alone on the 
structure of the anal sphincter from these results. 
 
Effects of RT on the PFM function 
From the ten articles addressing the muscle function aspects, four excellent quality studies 
(scores from 83 to 96 %) supported a significant effect of RT on PFM function. In addition to its 
excellent quality, the study by Dieperink et al. [38] presented the strongest study design: a 
single-blind randomized controlled trial from which there is level 1B evidence that RT affects the 
PFM function, between 1 and 25 months after radiation, in a population of men treated with 
intensity-modulated RT for prostate cancer. From supplemental statistics, highly significant 
differences were found for the EMG average work and resting activity variables, which strongly 
supports the impacts of RT on PFM function. The study by Lorenzi et al. supports also that there 
are detrimental effects of radiation on muscle function [37]. Even though their methodological 
quality was excellent, their cross-sectional study was on a small sample size (total n = 11) and 
prevented the authors from presenting higher than level 4 evidence. The authors showed, with 
in vitro dynamometry significantly less spontaneous muscle activity in irradiated muscle strips 
compared to controls, a decreased number of contractions in response to electrical and 
chemical stimulation, for anal sphincter strips of men and women treated with RT for rectal 
cancer. With an excellent methodological quality and a 2B level of evidence, the study of Lim et 
al. strongly supports that there is a significant decrease in maximal squeeze pressure upon 
anorectal manometry [39]. Furthermore, the article by Yeoh et al. [34] presented no detrimental 
effect of RT on PFM function, with a level 2B evidence and an excellent methodological quality, 
in a population of men 1 year post-irradiation for prostate cancer. Surprisingly, their findings 
showed higher resting pressure than at baseline. Their cohort still reported many PFM 
dysfunction such as urgency and fecal incontinence, and the unexpected results of anal resting 
pressure were not further discussed, nor analyzed for confoundings or possible bias. The other 
reviewed articles [36, 40, 29, 30, 33], although most of lesser methodological quality (high drop-
out rates, younger controls, etc.), all generally point toward detrimental effects of RT on the 
PFM function. This is in concordance with what was observed by Krol et al. [49] in their 
systematic review on anal and rectal after EBRT for prostate cancer, where decreased anal 
resting pressure was supported by low to moderate evidence. Lastly, the study by Allgayer et al. 
[28] demonstrated no significant differences in PFM function. Again, this study with a good 
methodology quality is lacking of essential information for results’ interpretation. 
There are some limits to this review. For instance, it is likely that the quality of the selected 
studies was slightly overestimated. Indeed, we gave the maximum score for the criterion related 
to outcome measures when there was a clear description of the outcome used. This was the 
case for 11 of the 13 selected studies. However, the literature regarding the metrology of the 
measurement tools was not reviewed. Serving as an example, anorectal manometry was used to 
measure PFM function in seven studies, yet it is known to lack reliability to measure maximal 
squeeze pressure [48, 50]. Digital palpation was used in two other studies [36, 38] but lacks 
objectivity and precision. Indeed, using palpation as an assessment tool is very accessible and 
practical but is also limited for appreciating large differences of force [41, 51]. In the study of de 
Noronha et al. [36], the limited ability of the digital assessment method to detect muscle 
strength with more precision seems to have diminished the potentiality of the authors to bring 
out the intergroup differences through descriptive statistics. In addition, no differences could be 
seen with pre- to post-radiation variables when measured digitally in the trial of Dieperink et al. 
[38], although other measures showed that there was an impact of RT on function from EMG 
activity for maximal voluntary contraction. In future studies, particular attention should be paid 
to choose tools with good measurement properties to characterize PFM function, especially to 
estimate strength and pressure variables. Lastly, we must mention the heterogeneity of cancer 
types and RT treatment protocols between the articles retained. Although RT to different pelvic 
organs (prostate, rectum and colon, cervix, etc.) can affect the PFMs in a similar fashion because 
of their analogous proximity to the musculature and their comparable dose tolerance limits, 
discrepancies between the effects of different protocols cannot be ignored. This review allows 
the gathering of existing evidence about measurable PFM changes following RT, despite not 
being able to shed light on a clear dose-effect relationship between RT and PFMs because of this 
lack of homogeneity. 
Few articles measured the impacts of RT on the PFM structure or function in women treated for 
gynecological cancers, even though there are many studies reporting urinary, sexual, or fecal 
problems after radiotherapy versus surgery alone [4, 6, 9, 12, 11, 3, 52, 53]. In this review, only 
two papers met our criteria and could be included. Considering the large spectrum of pelvic 
floor dysfunctions after RT for these female cancers, further research detailing the resulting 
muscle function seems urgently needed in order to have more readily available treatment 
options for these problems. 
Conclusion 
This systematic review presents some evidence that pelvic irradiation used in the treatment of 
cancer of the pelvis has detrimental effects on the PFMs, especially on function. There is level 2B 
evidence of these effects on the structure of the PFMs, and these effects do not include change 
in anal sphincters maximal thickness. There is also level 1B evidence of RT effects on PFM 
function, mainly activity and contractile response during a maximal voluntary contraction when 
measured by EMG. Further higher methodological quality studies would be needed in order to 
increase the level of evidence to support this conclusion. The severity of muscle tissue damage 
and its relationship with the type of radiation or dosage remain unclear. Impacts of RT on the 
PFMs after gynecological cancer in women also remain understudied. A better understanding of 
muscle damage and dysfunction following RT will improve medical and rehabilitation 
interventions targeting the pelvic floor in the future. 
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Appendix 
Table 5 
Additional statistics from the study by Dieperink et al. 
  Pre Post Statistics 
Subjects 
(n) 
Mean 
(SD) 
Subjects 
(n) 
Mean 
(SD) 
Paired ttest 
(pvalue) 
SMD 
Maximal 
strength 
(digital) 
160 4.01 
(0.08) 
148 3.80 
(0.09) 
0.13 −2.51 
Static 
strength 
(digital) 
161 34.42 
(1.68) 
149 33.40 
(1.77) 
0.60 −0.60 
Dynamic 
strength 
(number of 
contractions) 
161 22.19 
(1.18) 
149 20.15 
(1.19) 
0.23 −1.73 
EMG 
(average 
during 
activity) 
156 38.21 
(1.72) 
143 31.49 
(1.37) 
>0.0001 −3.91 
EMG 
(average at 
rest) 
148 6.87 
(0.32) 
134 5.66 
(0.25) 
0.001 −3.80 
Source: [38] 
SMD standardized mean difference 
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